Ionis Pharmaceuticals, Inc. Earnings

Ionis Pharmaceuticals, Inc.’s revenue jumped 100.69% since last year same period to $452.05Mn in the Q2 2025. On a quarterly growth basis, Ionis Pharmaceuticals, Inc. has generated 243.47% jump in its revenue since last 3-months.

Ionis Pharmaceuticals, Inc.’s net profit jumped 286.45% since last year same period to $123.55Mn in the Q2 2025. On a quarterly growth basis, Ionis Pharmaceuticals, Inc. has generated 184.08% jump in its net profits since last 3-months.

Ionis Pharmaceuticals, Inc.’s net profit margin jumped 192.91% since last year same period to 27.33% in the Q2 2025. On a quarterly growth basis, Ionis Pharmaceuticals, Inc. has generated 124.48% jump in its net profit margins since last 3-months.

Ionis Pharmaceuticals, Inc.’s earning per share (EPS) estimates for the current quarter stand at -1.2 - a -400% fall from last quarter’s estimates.

Ionis Pharmaceuticals, Inc.’s earning per share (EPS) estimates for the current year stand at -1.2.

Ionis Pharmaceuticals, Inc.’s earning per share (EPS) jumped 100% since last year same period to 0 in the Q3 2025. This indicates that the Ionis Pharmaceuticals, Inc. has generated 100% annual rate of jump in its earning per share (EPS) in the last 4 quarters.